Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis

Familial hypobetalipoproteinemia (FHBL) is a rare genetic disorder of lipid metabolism that is associated with abnormally low serum levels of low-density lipoprotein (LDL) cholesterol and apolipoprotein B. It is an autosomal co-dominant disorder, and depending on zygosity, the clinical manifestation...

Full description

Bibliographic Details
Main Authors: Mindy C.W. Lam, Janakie Singham, Robert A. Hegele, Maziar Riazy, Matti A. Hiob, Gordon Francis, Urs P. Steinbrecher
Format: Article
Language:English
Published: Karger Publishers 2012-07-01
Series:Case Reports in Gastroenterology
Subjects:
Online Access:http://www.karger.com/Article/FullText/339761
_version_ 1811314785398030336
author Mindy C.W. Lam
Janakie Singham
Robert A. Hegele
Maziar Riazy
Matti A. Hiob
Gordon Francis
Urs P. Steinbrecher
author_facet Mindy C.W. Lam
Janakie Singham
Robert A. Hegele
Maziar Riazy
Matti A. Hiob
Gordon Francis
Urs P. Steinbrecher
author_sort Mindy C.W. Lam
collection DOAJ
description Familial hypobetalipoproteinemia (FHBL) is a rare genetic disorder of lipid metabolism that is associated with abnormally low serum levels of low-density lipoprotein (LDL) cholesterol and apolipoprotein B. It is an autosomal co-dominant disorder, and depending on zygosity, the clinical manifestations may vary from none to neurological, endocrine, hematological or liver dysfunction. Nonalcoholic fatty liver disease is common in persons with FHBL, however progression to nonalcoholic steatohepatitis is unusual. We describe here a patient with a novel APOB mutation, V703I, which appears to contribute to the severity of the FHBL phenotype. He had liver enzyme abnormalities, increased echogenicity of the liver consistent with steatosis, very low LDL cholesterol at 0.24 mmol/l (normal 1.8–3.5 mmol/l) and an extremely low apolipoprotein B level of 0.16 g/l (normal 0.6–1.2 g/l). APOB gene sequencing revealed him to be a compound heterozygote with two mutations (R463W and V703I). APOB R463W has previously been reported to cause FHBL. Genetic sequencing of his first-degree relatives identified the APOB V703I mutation in his normolipidemic brother and father and the APOB R463W mutation in his mother and sister, both of whom have very low LDL cholesterol levels. These results suggest that the APOB V703I mutation alone does not cause the FHBL phenotype. However, it is possible that it has a contributory role to a more aggressive phenotype in the presence of APOB R463W.
first_indexed 2024-04-13T11:18:31Z
format Article
id doaj.art-260e8de5d6d64bb58d39bb8b2c1ded82
institution Directory Open Access Journal
issn 1662-0631
language English
last_indexed 2024-04-13T11:18:31Z
publishDate 2012-07-01
publisher Karger Publishers
record_format Article
series Case Reports in Gastroenterology
spelling doaj.art-260e8de5d6d64bb58d39bb8b2c1ded822022-12-22T02:48:53ZengKarger PublishersCase Reports in Gastroenterology1662-06312012-07-016242943710.1159/000339761339761Familial Hypobetalipoproteinemia-Induced Nonalcoholic SteatohepatitisMindy C.W. LamJanakie SinghamRobert A. HegeleMaziar RiazyMatti A. HiobGordon FrancisUrs P. SteinbrecherFamilial hypobetalipoproteinemia (FHBL) is a rare genetic disorder of lipid metabolism that is associated with abnormally low serum levels of low-density lipoprotein (LDL) cholesterol and apolipoprotein B. It is an autosomal co-dominant disorder, and depending on zygosity, the clinical manifestations may vary from none to neurological, endocrine, hematological or liver dysfunction. Nonalcoholic fatty liver disease is common in persons with FHBL, however progression to nonalcoholic steatohepatitis is unusual. We describe here a patient with a novel APOB mutation, V703I, which appears to contribute to the severity of the FHBL phenotype. He had liver enzyme abnormalities, increased echogenicity of the liver consistent with steatosis, very low LDL cholesterol at 0.24 mmol/l (normal 1.8–3.5 mmol/l) and an extremely low apolipoprotein B level of 0.16 g/l (normal 0.6–1.2 g/l). APOB gene sequencing revealed him to be a compound heterozygote with two mutations (R463W and V703I). APOB R463W has previously been reported to cause FHBL. Genetic sequencing of his first-degree relatives identified the APOB V703I mutation in his normolipidemic brother and father and the APOB R463W mutation in his mother and sister, both of whom have very low LDL cholesterol levels. These results suggest that the APOB V703I mutation alone does not cause the FHBL phenotype. However, it is possible that it has a contributory role to a more aggressive phenotype in the presence of APOB R463W.http://www.karger.com/Article/FullText/339761Familial hypobetalipoproteinemiaNonalcoholic steatohepatitisAPOB
spellingShingle Mindy C.W. Lam
Janakie Singham
Robert A. Hegele
Maziar Riazy
Matti A. Hiob
Gordon Francis
Urs P. Steinbrecher
Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
Case Reports in Gastroenterology
Familial hypobetalipoproteinemia
Nonalcoholic steatohepatitis
APOB
title Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
title_full Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
title_fullStr Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
title_full_unstemmed Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
title_short Familial Hypobetalipoproteinemia-Induced Nonalcoholic Steatohepatitis
title_sort familial hypobetalipoproteinemia induced nonalcoholic steatohepatitis
topic Familial hypobetalipoproteinemia
Nonalcoholic steatohepatitis
APOB
url http://www.karger.com/Article/FullText/339761
work_keys_str_mv AT mindycwlam familialhypobetalipoproteinemiainducednonalcoholicsteatohepatitis
AT janakiesingham familialhypobetalipoproteinemiainducednonalcoholicsteatohepatitis
AT robertahegele familialhypobetalipoproteinemiainducednonalcoholicsteatohepatitis
AT maziarriazy familialhypobetalipoproteinemiainducednonalcoholicsteatohepatitis
AT mattiahiob familialhypobetalipoproteinemiainducednonalcoholicsteatohepatitis
AT gordonfrancis familialhypobetalipoproteinemiainducednonalcoholicsteatohepatitis
AT urspsteinbrecher familialhypobetalipoproteinemiainducednonalcoholicsteatohepatitis